ARTICLE | Company News
J&J, The Carlyle Group deal
April 7, 2014 7:00 AM UTC
Johnson & Johnson accepted a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical Diagnostics business for $4.2 billion in cash. The pharma does not break out sale...